LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 47 filers reported holding LARIMAR THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,154,127 | +26.2% | 292,184 | 0.0% | 0.24% | +58.1% |
| Q2 2023 | $914,536 | -30.9% | 292,184 | 0.0% | 0.16% | -45.6% |
| Q1 2023 | $1,323,594 | +9.7% | 292,184 | 0.0% | 0.28% | -31.5% |
| Q4 2022 | $1,206,720 | +29.1% | 292,184 | 0.0% | 0.42% | +23.4% |
| Q3 2022 | $935,000 | +63.2% | 292,184 | 0.0% | 0.34% | +86.2% |
| Q2 2022 | $573,000 | -51.6% | 292,184 | 0.0% | 0.18% | -29.0% |
| Q1 2022 | $1,183,000 | -62.5% | 292,184 | 0.0% | 0.26% | -41.8% |
| Q4 2021 | $3,153,000 | -6.4% | 292,184 | 0.0% | 0.44% | +9.8% |
| Q3 2021 | $3,369,000 | +17.4% | 292,184 | 0.0% | 0.40% | +33.9% |
| Q2 2021 | $2,869,000 | -32.8% | 292,184 | 0.0% | 0.30% | -62.2% |
| Q1 2021 | $4,269,000 | -31.8% | 292,184 | 0.0% | 0.79% | -43.8% |
| Q4 2020 | $6,256,000 | +41.2% | 292,184 | 0.0% | 1.40% | +88.1% |
| Q3 2020 | $4,432,000 | +18.0% | 292,184 | 0.0% | 0.75% | -22.1% |
| Q2 2020 | $3,755,000 | – | 292,184 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,473,366 | $14,345,001 | 3.82% |
| Opaleye Management Inc. | 1,560,000 | $6,442,800 | 2.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $69,967,804 | 1.45% |
| GREAT POINT PARTNERS LLC | 1,273,635 | $5,260,113 | 1.03% |
| DAFNA Capital Management LLC | 473,136 | $1,954,052 | 0.55% |
| COMMODORE CAPITAL LP | 750,000 | $3,098 | 0.47% |
| Cheyne Capital Management (UK) LLP | 63,680 | $262,998 | 0.46% |
| Atlas Venture Advisors, Inc. | 292,184 | $1,206,720 | 0.42% |
| Perceptive Advisors | 2,860,000 | $11,811,800 | 0.33% |
| MANGROVE PARTNERS IM, LLC | 1,292,812 | $5,339,314 | 0.30% |